COVID-19-Related Neurologic Disorders Confer Greater In-Hospital Mortality
Neurologic disorders in hospitalized patients with coronavirus disease 2019 (COVID-19) are associated with increased in-hospital mortality.
COVID19
Social Activity Tied to Integrity of Brain Structure in Older Adults
For older adults, SE is associated with greater microstructural integrity of specific GM regions relevant to social cognition, which have roles in dementia.
Neurologic Manifestations Seen in Most Hospitalized With COVID-19
Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients.
Loss of Smell Prevalent in Those With SARS-CoV-2 Antibodies
Loss of smell is prevalent among individuals with severe acute respiratory syndrome coronavirus 2 antibodies.
Remdesivir Cuts Time to COVID-19 Recovery
For patients hospitalized with COVID-19, remdesivir is superior for shortening time to recovery compared with placebo.
Stroke Incidence Slightly Higher in Hospitalized Patients With COVID-19
Patients hospitalized with COVID-19, especially of older age and with stroke risk factors, have a slightly higher frequency of stroke compared with the general population.
COVID-19 Mortality Higher in Patients With Parkinson Disease
COVID-19-related case fatality rates are higher for patients with Parkinson disease, independent of age, sex, and race.
CDC Now Acknowledges Airborne Transmission of COVID-19
Infection with the new coronavirus can occur through airborne transmission between people farther than 6 feet apart.
Neurologic Manifestations of COVID-19 May Involve Cytokine Release Syndrome
Neurologic disturbances in patients with coronavirus disease 2019 were accompanied by evidence of cytokine release syndrome.
Red Flags of Past Medical History Common in Patients With COVID-19 and Headache
While there was no universal one, red flags concerning prior medical history were present in almost all patients with COVID-19 who developed headache.
-
Loading...
-
Loading...
Next post in Migraine and Headache
